What are the major risk factors for acute mesenteric ischemia?

Major Risk Factors for Acute Mesenteric Ischemia

The major risk factors for acute mesenteric ischemia vary by subtype, but advanced age (particularly >75 years), atrial fibrillation, atherosclerotic disease, heart failure, and critical illness requiring vasopressors are the most important to recognize clinically. 1

Risk Factors by AMI Subtype

The 2022 World Society of Emergency Surgery guidelines emphasize that clinical scenario and risk factors differentiate the four main types of AMI, which is critical for diagnosis and management 1:

Mesenteric Arterial Embolism (25% of cases)

• Atrial fibrillation (present in nearly 50% of embolic AMI patients) 1
• Prior history of arterial embolism
• Pre-existing peripheral vascular disease (approximately one-third of patients) 1
• Left ventricular dysfunction with poor ejection fraction
• Cardiac valve disease (endocarditis)
• Atherosclerotic aorta

Mesenteric Arterial Thrombosis (40% of cases - now the most common)

• Chronic atherosclerotic disease with pre-existing stenosis 1
• History of chronic mesenteric ischemia (postprandial pain, weight loss, "food fear")
• Previous revascularization procedures
• Celiac artery occlusion (symptomatic SMA thrombosis usually accompanies this) 1
• Vasculitis, mesenteric dissection, or mycotic aneurysm

Important trend: The etiology has shifted over recent decades, with arterial thrombosis increasing from 20-35% historically to 40% currently, partly explained by modern anticoagulant therapy for atrial fibrillation 1.

Non-Occlusive Mesenteric Ischemia (NOMI) (25% of cases)

• Cardiac failure (most common precipitant) 1
• Sepsis and septic shock 1
• Use of vasoconstrictive agents/catecholamines 1
• Hypovolemia 1
• Renal failure 1
• Cardiac surgery using cardiopulmonary bypass 1
• Hemodialysis 1
• Recent surgery
• Critical illness requiring intensive care

Clinical pitfall: NOMI is increasing in prevalence due to improved intensive care allowing more critically ill patients to survive, but it carries extremely high mortality, particularly when associated with high-dose vasoactive drugs 1.

Mesenteric Venous Thrombosis (<10% of cases)

Inherited hypercoagulable states:

• Factor V Leiden
• Prothrombin mutation
• Protein S deficiency
• Protein C deficiency
• Antithrombin deficiency
• Antiphospholipid syndrome
• Fibrinolysis shutdown (resistance to tPA) 1

Acquired hypercoagulable states:

• Malignancies
• Hematologic disorders
• Oral contraceptives 1

Local inflammatory/surgical factors:

• Acute pancreatitis
• Inflammatory bowel disease
• Splenectomy
• Bariatric surgery 1

Note: In young patients, 36% of MVT occurs without an obvious cause 1.

Universal Risk Factors Across All Types

Age

• Exponentially increasing risk with age 1
• In patients ≥75 years, AMI is more prevalent than appendicitis as a cause of acute abdomen
• An 80-year-old has roughly 10-fold higher incidence than a 60-year-old 1

Emerging Risk Factors

• COVID-19 infection - related to large vessel thromboembolic events and small vessel thrombosis from hypercoagulability and fibrinolysis shutdown 1
• Abdominal compartment syndrome with very high intra-abdominal pressure 1

Postoperative Cardiac Surgery-Specific Risk Factors

For patients undergoing cardiac surgery, a 2017 meta-analysis identified 14 significant risk factors 2:

Preoperative:

• Advanced age (mean difference 4.62 years)
• Cardiac shock (OR 5.17)
• Peripheral vascular disease (OR 3.53)
• Need for intra-aortic balloon pump (OR 5.89)
• Emergency surgery (OR 3.75)

Postoperative:

• Atrial fibrillation (OR 2.41)
• Serum creatinine >200 μmol/L (OR 23.39)
• Prolonged ventilation (OR 9.04)
• Need for IABP (OR 6.32)
• Inotropic treatment (OR 8.40)
• Blood transfusion (OR 9.15)
• Reoperation (OR 3.30)

Clinical Application

When evaluating a patient for possible AMI, maintain high clinical suspicion in:

• Elderly patients (especially >75 years) with cardiovascular disease
• Patients with atrial fibrillation presenting with acute abdominal pain
• Critically ill patients on vasopressors developing abdominal symptoms
• Patients with known atherosclerotic disease and history of postprandial pain
• Young patients with hypercoagulable states and abdominal pain

The guideline emphasizes that severe abdominal pain out of proportion to physical examination findings should be assumed to be AMI until disproven (strong recommendation) 1.